Delivery Order SPE2DB22D1202-SPE2DB24FUWV8
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a $19,407.76 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide DESCOVY 200-25 MG TABLET UU 30S pharmaceutical products. This delivery order falls under a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA, which serves as the primary vehicle for the company to deliver pharmaceuticals and medical...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $5,634.07 firm fixed price delivery order contract for the provision of DESCOVY 200-25 MG TABLET medication. This delivery order is part of a larger, single award indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025....
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for $5,922.24 to supply DESCOVY 200-25 MG TABLET pharmaceutical products. This order has a completion date of February 13, 2024 and was awarded on February 12, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This delivery order is issued under an indefinite delivery contract (IDC)...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide DESCOVY 200-25 MG TABLET UU 30S pharmaceuticals. The $16,063.69 contract has a completion date of February 26, 2024. Amerisourcebergen Drug Corp is the prime contractor and there were no set-aside designations for this award. This delivery order is part of a larger indefinite delivery contract (IDC) between Amerisourcebergen Drug...
- This is a delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of DESCOVY 200-25 MG TABLET, a pharmaceutical product, with a ceiling value of $25,160.03 and a performance period through July 11, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 held by AmerisourceBergen with the DLA Troop Support Medical, which provides a...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order (SPE2DX15D3012|SPE2DX24F8KZ8) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of DESCOVY 200-25 MG TABLET medication. The $29,665.90 contract has a performance period through March 21, 2024 and does not utilize any set-aside designations. This delivery order is issued under an indefinite delivery contract (IDC) with a $999,999,999.00 ceiling...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of DESCOVY 200-25 mg tablets in quantities of 30 units, with a ceiling value of $11,202.71. This is a firm fixed price delivery order with an ultimate completion date of December 2, 2025. The contract was competitively awarded with no set-aside designation, and performance will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of DESCOVY 200-25 MG TABLET UU 30S. The $2,589.45 award has a completion date of February 27, 2024. Amerisourcebergen Drug Corp is a prime contractor for DLA Troop Support Medical, providing a range of pharmaceutical products and medical supplies to support military treatment programs and facilities. This delivery order...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract, valued at $82,726.96, is for the delivery of DESCOVY 200-25 MG TABLET UU 30S, a pharmaceutical product. This delivery order was issued under an Indefinite Delivery Contract (IDC) that AmerisourceBergen Drug Corp holds with DLA, with a potential value of up to $999,999,999.00 and a...
- The U.S. Defense Logistics Agency (DLA) awarded a $3,956.17 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp for the supply of DESCOVY 200-25 MG TABLET, a pharmaceutical product. This order falls under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, which enables the agency to efficiently procure a comprehensive range of medical commodities to support military treatment programs and facilities...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB24FUWV8Delivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of DESCOVY 200-25 MG TABLET UU 30S, a pharmaceutical product. The contract has a ceiling value of $11,113.25 and a period of performance through April 15, 2024. This delivery order is part of a larger, single-award indefinite delivery contract (IDC) between DLA and AmerisourceBergen Drug Corp, valued at up to $999,999,999.00 with a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for AmerisourceBergen Drug Corp to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this particular delivery order.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.1k | 4/12/24 |